Inhibition of Restenosis Formation Without Compromising Reendothelialization as a Potential Solution to Thrombosis Following Angioplasty?

REFERENCES

• Armeanu S., Pelisek J., Krausz E., Fuchs A., Groth D., Curth R., Keil O., Quilici J., Rolland P. H., Reszka R., Nikol S. Optimization of nonviral gene transfer of vascular smooth muscle cells in vitro and in vivo. Molecular Therapy 2000; 1: 366–375
   PubMed Web of Science ®Google Scholar
• Asahara T., Chen D., Tsurumi Y., Kearney M., Rossow S., Passeri J., Symes J. F., Isner J. M. Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer. Circulation 1996; 94: 3291–3302
   PubMed Web of Science ®Google Scholar
• Barr C. S., Rhodes P., Struthers A. D. C-type natriuretic peptide. Peptides 1996; 17: 1243–1251
   PubMed Web of Science ®Google Scholar
• Deiner C., Schwimmbeck P. L., Koehler I. S., Loddenkemper C., Noutsias M., Nikol S., Schultheiss H. P., Yla-Herttuala S., Pels K. Adventitial VEGF165 gene transfer prevents lumen loss through induction of positive arterial remodeling after PTCA in porcine coronary arteries. Atherosclerosis 2006; 189: 123–132
   PubMed Web of Science ®Google Scholar
• Engelmann M. G., Shimizu M., Pelisek J., Fuchs A., Golda A., Mekkaoui C., Fraunberger P., Rolland P. H., Nikol S. Comparison of surgical versus endovascular occlusion models in pig femoral arteries. Journal of Endovascular Therapy 2004; 11: 71–79
   PubMed Web of Science ®Google Scholar
• Erbel R., Haude M., Hopp H. W., Franzen D., Rupprecht H. J., Heublein B., Fischer K., de Jaegere P., Serruys P., Rutsch W., Probst P. Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group. New England Journal of Medicine 1998; 339: 1672–1678
   PubMed Web of Science ®Google Scholar
• Garg U. C., Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. Journal of Clinical Investigation 1989; 83: 1774–1777
   PubMed Web of Science ®Google Scholar
• Hedman M., Hartikainen J., Syvanne M., Stjernvall J., Hedman A., Kivela A., Vanninen E., Mussalo H., Kauppila E., Simula S., Narvanen O., Rantala A., Peuhkurinen K., Nieminen M. S., Laakso M., Yla-Herttuala S. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: Phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 2003; 107: 2677–2683
   PubMed Web of Science ®Google Scholar
• Huehns T. Y., Krausz E., Mrochen S., Schmid M., Engelmann M. G., Esin S., Schrittenloher P. K., Hofling B., Gunzburg W. H., Nikol S. Neointimal growth can be influenced by local adventitial gene manipulation via a needle injection catheter. Atherosclerosis 1999; 144: 135–150
   PubMed Web of Science ®Google Scholar
• Korovesis S., Karvouni E., Giazitzoglou E., Katritsis D. Drug-eluting stents: Immediate and long-term results. Hellenic Journal of Cardiology 2005; 46: 330–335
   PubMedGoogle Scholar
• Lemos P. A., Saia F., Ligthart J. M., Arampatzis C. A., Sianos G., Tanabe K., Hoye A., Degertekin M., Daemen J., McFadden E., Hofma S., Smits P. C., De Feyter P., Van Der Giessen W. J., Van Domburg R. T., Serruys P. W. Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases. Circulation 2003; 108: 257–260
   PubMed Web of Science ®Google Scholar
• Lemos P. A., Serruys P. W., Van Domburg R. T., Saia F., Arampatzis C. A., Hoye A., Degertekin M., Tanabe K., Daemen J., Liu T. K., McFadden E., Sianos G., Hofma S. H., Smits P. C., Van Der Giessen W. J., De Feyter P. J. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the “real world”: The Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation 2004; 109: 190–195
   PubMed Web of Science ®Google Scholar
• Levin E. R., Gardner D. G., Samson W. K. Natriuretic peptides. New England Journal of Medicine 1998; 339: 321–328
   PubMed Web of Science ®Google Scholar
• Liistro F., Colombo A. Late acute thrombosis after paclitaxel eluting stent implantation. Heart 2001; 86: 262–264
   PubMed Web of Science ®Google Scholar
• Liistro F., Fineschi M., Angioli P., Sinicropi G., Falsini G., Gori T., Ducci K., Bravi A., Bolognese L. Effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis: The TRUE (Tuscany Registry of Sirolimus for Unselected In-Stent Restenosis) Registry. Journal of the American College of Cardiology 2006; 48: 270–275
   PubMed Web of Science ®Google Scholar
• Morice M. C., Serruys P. W., Sousa J. E., Fajadet J., Ban H. E., Perin M., Colombo A., Schuler G., Barragan P., Guagliumi G., Molnar F., Falotico R. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. New England Journal of Medicine 2002; 346: 1773–1780
   PubMed Web of Science ®Google Scholar
• Morishige K., Shimokawa H., Yamawaki T., Miyata K., Eto Y., Kandabashi T., Yogo K., Higo T., Egashira K., Ueno H., Takeshita A. Local adenovirus-mediated transfer of C-type natriuretic peptide suppresses vascular remodeling in porcine coronary arteries in vivo. Journal of the American College of Cardiology 2000; 35: 1040–1047
   PubMed Web of Science ®Google Scholar
• Morishita R., Gibbons G. H., Ellison K. E., Nakajima M., von der L. H., Zhang L., Kaneda Y., Ogihara T., Dzau V. J. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. Journal of Clinical Investigation 1994; 93: 1458–1464
   PubMed Web of Science ®Google Scholar
• Naruko T., Ueda M., van der Wal A. C., van der Loos C. M., Itoh H., Nakao K., Becker A. E. C-type natriuretic peptide in human coronary atherosclerotic lesions. Circulation 1996; 94: 3103–3108
   PubMed Web of Science ®Google Scholar
• Neumann F. J., Desmet W., Grube E., Brachmann J., Presbitero P., Rubartelli P., Mugge A., Di Pede F., Fullgraf D., Aengevaeren W., Spedicato L., Popma J. J. Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement. Circulation 2005; 111: 2107–2111
   PubMed Web of Science ®Google Scholar
• Nikol S., Huehns T. Y., Krausz E., Armeanu S., Engelmann M. G., Winder D., Salmons B., Hoefling B. Needle injection catheter delivery of the gene for an antibacterial agent inhibits neointimal formation. Gene Therapy 1999; 6: 737–748
   PubMed Web of Science ®Google Scholar
• Nikol S., Pelisek J., Engelmann M. G., Shimizu M., Fuchs A., Golda A., Armeanu S., Mekkaoui C., Rolland P. H. Vascular endothelial growth factor (VEGF165) and its influence on angiogenesis versus arteriogenesis in different vascular beds. Journal of Endovascular Therapy 2002; 9: 842–854
   PubMed Web of Science ®Google Scholar
• Ohno N., Itoh H., Ikeda T., Ueyama K., Yamahara K., Doi K., Yamashita J., Inoue M., Masatsugu K., Sawada N., Fukunaga Y., Sakaguchi S., Sone M., Yurugi T., Kook H., Komeda M., Nakao K. Accelerated reendothelialization with suppressed thrombogenic property and neointimal hyperplasia of rabbit jugular vein grafts by adenovirus-mediated gene transfer of C-type natriuretic peptide. Circulation 2002; 105: 1623–1626
   PubMed Web of Science ®Google Scholar
• Ong A. T., McFadden E. P., Regar E., de Jaegere P. P., Van Domburg R. T., Serruys P. W. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. Journal of the American College of Cardiology 2005; 45: 2088–209
   PubMed Web of Science ®Google Scholar
• Park S. J., Shim W. H., Ho D. S., Raizner A. E., Park S. W., Hong M. K., Lee C. W., Choi D., Jang Y., Lam R., Weissman N. J., Mintz G. S. A paclitaxel-eluting stent for the prevention of coronary restenosis. New England Journal of Medicine 2003; 348: 1537–1545
   PubMed Web of Science ®Google Scholar
• Pelisek J., Armeanu S., Nikol S. Quiescence, cell viability, apoptosis and necrosis of smooth muscle cells using different growth inhibitors. Cell Proliferation 2001; 34: 305–320
   PubMed Web of Science ®Google Scholar
• Pelisek J., Engelmann M. G., Golda A., Fuchs A., Armeanu S., Shimizu M., Mekkaoui C., Rolland P. H., Nikol S. Optimization of nonviral transfection: variables influencing liposome-mediated gene transfer in proliferating vs. quiescent cells in culture and in vivo using a porcine restenosis model. Journal of Molecular Medicine 2002; 80: 724–736
   PubMed Web of Science ®Google Scholar
• Pelisek J., Kuehnl A., Rolland P. H., Mekkaoui C., Fuchs A., Walker G. F., Ogris M., Wagner E., Nikol S. Functional analysis of genomic DNA, cDNA, and nucleotide sequence of the mature C-type natriuretic peptide gene in vascular cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2004; 24: 1646–1651
   PubMed Web of Science ®Google Scholar
• Popma J. J., Ellis S. G. Intracoronary stents: clinical and angiographic results. Herz 1990; 15: 307–318
   PubMed Web of Science ®Google Scholar
• Savage M. P., Fischman D. L., Schatz R. A., Teirstein P. S., Leon M. B., Baim D., Ellis S. G., Topol E. J., Hirshfeld J. W., Cleman M. W. Long-term angiographic and clinical outcome after implantation of a balloon-expandable stent in the native coronary circulation. Palmaz-Schatz Stent Study Group. Journal of the American College of Cardiology 1994; 24: 1207–1212
   PubMed Web of Science ®Google Scholar
• Scheller B., Hehrlein C., Bocksch W., Rutsch W., Haghi D., Dietz U., Bohm M., Speck U. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. New England Journal of Medicine 2006; 355: 2113–2124
   PubMed Web of Science ®Google Scholar
• Scheller B., Speck U., Abramjuk C., Bernhardt U., Bohm M., Nickenig G. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 2004; 110: 810–814
   PubMed Web of Science ®Google Scholar
• Shuchman M. Trading restenosis for thrombosis? New questions about drug-eluting stents. New England Journal of Medicine 2006; 355: 1949–1952
   PubMed Web of Science ®Google Scholar
• Stone G. W., Ellis S. G., Cannon L., Mann J. T., Greenberg J. D., Spriggs D., O'Shaughnessy C. D., DeMaio S., Hall P., Popma J. J., Koglin J., Russell M. E. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. Journal of the American Medical Association 2005; 294: 1215–1223
   PubMed Web of Science ®Google Scholar
• Suzuki T., Yamazaki T., Yazaki Y. The role of the natriuretic peptides in the cardiovascular system. Cardiovascular Research 2001; 51: 489–494
   PubMed Web of Science ®Google Scholar
• Van Der Giessen W. J., Lincoff A. M., Schwartz R. S., van Beusekom H. M., Serruys P. W., Holmes D. R., Jr., Ellis S. G., Topol E. J. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 1996; 94: 1690–1697
   PubMed Web of Science ®Google Scholar
• Virmani R., Guagliumi G., Farb A., Musumeci G., Grieco N., Motta T., Mihalcsik L., Tespili M., Valsecchi O., Kolodgie F. D. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: Should we be cautious?. Circulation 2004; 109: 701–705
   PubMed Web of Science ®Google Scholar
• Virmani R., Liistro F., Stankovic G., Di Mario C., Montorfano M., Farb A., Kolodgie F. D., Colombo A. Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans. Circulation 2002; 106: 2649–2651
   PubMed Web of Science ®Google Scholar
• Walter D. H., Cejna M., Diaz-Sandoval L., Willis S., Kirkwood L., Stratford P. W., Tietz A. B., Kirchmair R., Silver M., Curry C., Wecker A., Yoon Y. S., Heidenreich R., Hanley A., Kearney M., Tio F. O., Kuenzler P., Isner J. M., Losordo D. W. Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis. Circulation 2004; 110: 36–45
   PubMed Web of Science ®Google Scholar
• Yla-Herttuala S. An update on angiogenic gene therapy: Vascular endothelial growth factor and other directions. Current Opinions in Molecular Therapy 2006; 8: 295–300
   PubMed Web of Science ®Google Scholar